Trademark search for:

ADDIMMUNE

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results

Also check across:

USPTO Filing History

Key events recorded for this trademark application

2023-02-21 — Application filed
2023-02-24 — Application filed
2023-03-12 — Application filed
2023-07-13 — Letter of protest evidence forwarded
2023-11-19 — Assigned to examiner
2023-11-22 — Letter of protest evidence reviewed-no further action taken
2023-11-22 — Final disposition recorded
2023-11-22 — Final disposition recorded
2023-11-22 — Final disposition recorded
2024-02-20 — Application filed
2024-02-20 — Application filed
2024-08-08 — Examiners amendment -written
2024-08-08 — Examiners amendment e-mailed
2024-08-08 — Notification of examiners amendment e-mailed
2024-08-08 — Examiner's amendment entered
2024-08-08 — Approved for pub - principal register
2024-08-21 — Notification of notice of publication e-mailed
2024-09-10 — Published for opposition
2024-09-10 — Official gazette publication confirmation e-mailed
2024-11-05 — Noa e-mailed - sou required from applicant
2025-06-09 — Application abandoned
2025-06-09 — Application abandoned
2025-06-09 — Final status recorded

Owner Information

American Gene Technologies International Inc.
Rockville , MD

Correspondent

Michael A. Geller DLA PIPER LLP (US)
PO BOX 64807
CHICAGO, IL 60664-0807
United States

Filing Details

Filing Date:
2023-02-21

Status Date:
2025-06-09

Category:
Pharmaceuticals

Filing Year:
2023

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.